Skip to main content

Daniel Brennan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Daniel Brennan

Earlier roles on record: CFO at Boston Scientific Corp (BSX) until June 29, 2025. Boston Scientific Corp reported in an 8-K filed April 23, 2025 that Daniel Brennan retired as Executive Vice President and Chief Financial Officer, effective June 29, 2025. The proxy statement of Boston Scientific Corp reports total compensation of $6,282,896 for Daniel Brennan in fiscal 2025, including a base salary of $660,990. Disclosed compensation is on record for 9 fiscal years. Daniel Brennan has spoken on 12 earnings calls across 1 company, most recently for Boston Scientific Corp on April 23, 2025.

“On April 23, 2025, Boston Scientific Corporation (the "Company") announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025, and that Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025.”
Boston Scientific Corp Form 8-K, filed April 23, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Boston Scientific Corp (BSX) $660,990 $6,282,896
2024 Boston Scientific Corp (BSX) $843,146 $6,687,005
2023 Boston Scientific Corp (BSX) $801,528 $5,829,147
2022 Boston Scientific Corp (BSX) $765,959 $5,252,206
2021 Boston Scientific Corp (BSX) $692,183 $4,429,827
2020 Boston Scientific Corp (BSX) $560,422 $3,668,993
2019 Boston Scientific Corp (BSX) $655,437 $4,031,286
2018 Boston Scientific Corp (BSX) $621,637 $3,665,825
2017 Boston Scientific Corp (BSX) $593,194 $3,632,769

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.